Oncology and Hematology - Global Oncology Academy

545-560 of 789

MinuteCE®
Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers
Ignacio Duran, MD; Wenxin Xu, MD
1.25 credits 10 episodes
- Ignacio Duran, MD
- Wenxin Xu, MD
- Sandy Srinivas, MD
1.25 credits 10 episodes
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
MinuteCE®
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Ritu Salani, MD; Nicoletta Colombo, MD
1.00 program credit
- Ritu Salani, MD
- Nicoletta Colombo, MD
1.00 program credit
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Project Oncology®
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Constance Lehman, MD, PhD
- Constance Lehman, MD, PhD
Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma
Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma
MinuteCE®
Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma
Wenxin Xu, MD; Sandy Srinivas, MD
1.25 program credits
- Wenxin Xu, MD
- Sandy Srinivas, MD
1.25 program credits
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
MinuteCE®
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
Susana Campos, MD, MPH; Ritu Salani, MD
1.00 program credit
- Susana Campos, MD, MPH
- Ritu Salani, MD
1.00 program credit
Implementing Guideline-Concordant Care Into the Management of Frontline Patients With Recurrent Endometrial Cancer
Implementing Guideline-Concordant Care Into the Management of Frontline Patients With Recurrent Endometrial Cancer
MinuteCE®
Implementing Guideline-Concordant Care Into the Management of Frontline Patients With Recurrent Endometrial Cancer
Ritu Salani, MD; Susana Campos, MD, MPH
1.00 program credit
- Ritu Salani, MD
- Susana Campos, MD, MPH
1.00 program credit
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Project Oncology®
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Project Oncology®
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Heather Greenlee, ND, PhD, MPH
- Heather Greenlee, ND, PhD, MPH
The Potential Link Between COVID-19 and Cancer Regression
The Potential Link Between COVID-19 and Cancer Regression
Clinician's Roundtable
The Potential Link Between COVID-19 and Cancer Regression
Ankit Bharat, MD; Brian P. McDonough, MD, FAAFP
- Ankit Bharat, MD
- Brian P. McDonough, MD, FAAFP
The Future of ITP Care: Exploring New Treatments
The Future of ITP Care: Exploring New Treatments
Project Oncology®
The Future of ITP Care: Exploring New Treatments
Michele Lambert, MD, MSTR
- Michele Lambert, MD, MSTR
Understanding iMCD Through RNA Sequencing
Understanding iMCD Through RNA Sequencing
Project Oncology®
Understanding iMCD Through RNA Sequencing
Michael Gonzalez, PhD, MSc
- Michael Gonzalez, PhD, MSc
Revolutionizing Breast Cancer Care: The Emerging Role of Liquid Biopsy Technologies
Revolutionizing Breast Cancer Care: The Emerging Role of Liquid Biopsy Technologies
Project Oncology®
Revolutionizing Breast Cancer Care: The Emerging Role of Liquid Biopsy Technologies
Heather A. Parsons, MD, MPH
- Heather A. Parsons, MD, MPH
Diagnosing Castleman Disease: Key Considerations
Diagnosing Castleman Disease: Key Considerations
Project Oncology®
Diagnosing Castleman Disease: Key Considerations
Mateo Bustamante
- Mateo Bustamante
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Project Oncology®
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Joshua Brandstadter, MD, PhD, MSc
- Joshua Brandstadter, MD, PhD, MSc
Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC
Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC
MinuteCE®
Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC
Luis Paz-Ares, MD, PhD; Helena Yu, MD
1.00 program credit
- Luis Paz-Ares, MD, PhD
- Helena Yu, MD
- Matthew Gubens, MD, MS
1.00 program credit
Clinical evidence behind emerging targeted therapy strategies in patients with metastatic NSCLC
Clinical evidence behind emerging targeted therapy strategies in patients with metastatic NSCLC
MinuteCE®
Clinical evidence behind emerging targeted therapy strategies in patients with metastatic NSCLC
Luis Paz-Ares, MD, PhD; Helena Yu, MD
1.00 program credit
- Luis Paz-Ares, MD, PhD
- Helena Yu, MD
- Matthew Gubens, MD, MS
1.00 program credit

35/11